XML 57 R41.htm IDEA: XBRL DOCUMENT
v3.24.3

Capital Stock and Stockholders' Deficit (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Equity [Abstract] |  |
Schedule of Preferred Stock and Common Stock |  | The following table summarizes details of Legacy Allurion Preferred Stock authorized, issued, and outstanding immediately prior to the Business Combination (in thousands, except share amounts):
|  | Preferred Stock Authorized (1) |  |  | Preferred Stock Issued and Outstanding |  |  | Carrying Value |
Series A Preferred Stock |  |  | 2,276,786 |  |  |  | 2,276,786 |  |  | $ | 1,542 |
Series A-1 Preferred Stock |  |  | 1,513,028 |  |  |  | 1,486,048 |  |  |  | 2,842 |
Series B Preferred Stock |  |  | 2,298,929 |  |  |  | 2,245,515 |  |  |  | 5,253 |
Series C Preferred Stock |  |  | 8,113,616 |  |  |  | 7,927,446 |  |  |  | 39,122 |
Series D-1 Preferred Stock |  |  | 1,684,565 |  |  |  | 842,283 |  |  |  | 9,614 |
Series D-2 Preferred Stock |  |  | 3,644,616 |  |  |  | 3,644,616 |  |  |  | 24,054 |
Series D-3 Preferred Stock |  |  | 1,498,348 |  |  |  | 1,498,348 |  |  |  | 14,789 |
Total |  |  | 21,029,888 |  |  |  | 19,921,042 |  |  | $ | 97,216 |
The number of shares of Common Stock that have been reserved for the potential conversion or exercise, as applicable, of the Company’s securities as of December 31, 2023, is as follows:
Outstanding options to purchase common stock |  |  | 3,886,038 |
Restricted Stock Units |  |  | 643,635 |
Warrants to purchase preferred stock (as converted to warrants to purchase common stock) |  |  | 138,857 |
Warrants to purchase common stock |  |  | 264,801 |
Public warrants to purchase common stock |  |  | 18,759,838 |
Earn-Out shares |  |  | 9,000,000 |
Total |  |  | 32,693,169 |
Summary of Warrants to Purchase the Classes of Preferred Stock and Common Stock Outstanding | As of September 30, 2024, there were 403,658 Rollover Warrants outstanding to purchase Common Stock. Upon the closing of the Business Combination, certain Legacy Allurion preferred stock and Legacy Allurion common stock warrants that were converted into Rollover Warrants were determined to be equity classified. In connection with the Public Offering and Private Placement, we issued the Public Offering Warrants and Private Placement Warrants. As of September 30, 2024, there were 16,567,484 Public Offering Warrants and 2,260,159 Private Placement Warrants outstanding to purchase Common Stock.
September 30, 2024 |
Issuance Date |  | Remaining Contractual Term (in years) |  |  | Underlying Equity Instrument |  | Balance Sheet Classification |  |  | Shares Issuable Upon Exercise of Warrant |  |  | Weighted Average Exercise Price |
12/1/2014 |  |  | 0.2 |  |  | Common Stock |  |  | Equity |  |  |  | 44,272 |  |  | $ | 2.44 |
3/30/2021 |  |  | 6.5 |  |  | Common Stock |  |  | Liability |  |  |  | 130,053 |  |  |  | 6.73 |
9/15/2022 |  |  | 8.0 |  |  | Common Stock |  |  | Liability |  |  |  | 45,238 |  |  |  | 12.14 |
6/4/2022 |  |  | 7.7 |  |  | Common Stock |  |  | Liability |  |  |  | 45,238 |  |  |  | 12.14 |
1/17/2017 |  |  | 2.3 |  |  | Common Stock |  |  | Equity |  |  |  | 73,349 |  |  |  | 0.02 |
8/3/2017 |  |  | 2.8 |  |  | Common Stock |  |  | Equity |  |  |  | 9,779 |  |  |  | 1.13 |
9/8/2017 |  |  | 2.9 |  |  | Common Stock |  |  | Liability |  |  |  | 28,764 |  |  |  | 1.05 |
6/19/2018 |  |  | 3.7 |  |  | Common Stock |  |  | Liability |  |  |  | 17,977 |  |  |  | 1.05 |
6/25/2019 |  |  | 4.7 |  |  | Common Stock |  |  | Liability |  |  |  | 8,988 |  |  |  | 1.05 |
7/1/2024 |  |  | 4.8 |  |  | Common Stock |  |  | Liability |  |  |  | 18,827,643 |  |  |  | 1.20 |
|  |  |  |  |  |  |  |  |  |  |  |  | 19,231,301 |  |  |  |  |
December 31, 2023 |
Issuance Date |  | Remaining Contractual Term (in years) |  |  | Underlying Equity Instrument |  | Balance Sheet Classification |  |  | Shares Issuable Upon Exercise of Warrant |  |  | Weighted Average Exercise Price |
12/1/2014 |  |  | 0.9 |  |  | Common Stock |  |  | Equity |  |  |  | 44,272 |  |  | $ | 2.44 |
3/30/2021 |  |  | 7.2 |  |  | Common Stock |  |  | Liability |  |  |  | 130,053 |  |  |  | 6.73 |
9/15/2022 |  |  | 8.7 |  |  | Common Stock |  |  | Liability |  |  |  | 45,238 |  |  |  | 12.14 |
6/4/2022 |  |  | 8.4 |  |  | Common Stock |  |  | Liability |  |  |  | 45,238 |  |  |  | 12.14 |
1/17/2017 |  |  | 3.0 |  |  | Common Stock |  |  | Equity |  |  |  | 73,349 |  |  |  | 0.02 |
8/3/2017 |  |  | 3.6 |  |  | Common Stock |  |  | Equity |  |  |  | 9,779 |  |  |  | 1.13 |
9/8/2017 |  |  | 3.7 |  |  | Common Stock |  |  | Liability |  |  |  | 28,764 |  |  |  | 1.05 |
6/19/2018 |  |  | 4.5 |  |  | Common Stock |  |  | Liability |  |  |  | 17,977 |  |  |  | 1.05 |
6/25/2019 |  |  | 5.5 |  |  | Common Stock |  |  | Liability |  |  |  | 8,988 |  |  |  | 1.05 |
|  |  |  |  |  |  |  |  |  |  |  |  | 403,658 |  |  |  |  |
| As of December 31, 2023, there were 403,658 such Rollover Warrants outstanding to purchase Common Stock. Upon the closing of the Business Combination, certain Legacy Allurion preferred stock and Legacy Allurion common stock warrants that were converted into Rollover Warrants were determined to be equity classified.
December 31, 2023 |
Issuance Date |  | Remaining Contractual Term (in years) |  |  | Underlying Equity Instrument |  | Balance Sheet Classification |  |  | Shares Issuable Upon Exercise of Warrant |  |  | Weighted Average Exercise Price |
12/1/2014 |  |  | 0.9 |  |  | Common stock |  |  | Equity |  |  |  | 44,272 |  |  | $ | 2.44 |
3/30/2021 |  |  | 7.2 |  |  | Common stock |  |  | Liability |  |  |  | 130,053 |  |  |  | 6.73 |
9/15/2022 |  |  | 8.7 |  |  | Common stock |  |  | Liability |  |  |  | 45,238 |  |  |  | 12.14 |
6/4/2022 |  |  | 8.4 |  |  | Common stock |  |  | Liability |  |  |  | 45,238 |  |  |  | 12.14 |
1/17/2017 |  |  | 3.0 |  |  | Common stock |  |  | Equity |  |  |  | 73,349 |  |  |  | 0.02 |
8/3/2017 |  |  | 3.6 |  |  | Common stock |  |  | Equity |  |  |  | 9,779 |  |  |  | 1.13 |
9/8/2017 |  |  | 3.7 |  |  | Common stock |  |  | Liability |  |  |  | 28,764 |  |  |  | 1.05 |
6/19/2018 |  |  | 4.5 |  |  | Common stock |  |  | Liability |  |  |  | 17,977 |  |  |  | 1.05 |
6/25/2019 |  |  | 5.5 |  |  | Common stock |  |  | Liability |  |  |  | 8,988 |  |  |  | 1.05 |
|  |  |  |  |  |  |  |  |  |  |  |  | 403,658 |  |  |  |  |
December 31, 2022 |
Issuance Date |  | Remaining Contractual Term (in years) |  |  | Underlying Equity Instrument |  | Balance Sheet Classification |  |  | Shares Issuable Upon Exercise of Warrant |  |  | Weighted Average Exercise Price |
4/1/2013 |  |  | 0.2 |  |  | Series A-1 Preferred Stock |  |  | Liability |  |  |  | 16,557 |  |  | $ | 1.95 |
12/1/2014 |  |  | 1.9 |  |  | Series B Preferred Stock |  |  | Liability |  |  |  | 60,768 |  |  |  | 2.44 |
3/30/2021 |  |  | 8.2 |  |  | Series C Preferred Stock |  |  | Liability |  |  |  | 130,053 |  |  |  | 6.73 |
9/15/2022 |  |  | 9.7 |  |  | Series D-1 Preferred Stock |  |  | Liability |  |  |  | 45,238 |  |  |  | 12.14 |
6/4/2022 |  |  | 9.4 |  |  | Series D-1 Preferred Stock |  |  | Liability |  |  |  | 45,238 |  |  |  | 12.14 |
1/17/2017 |  |  | 4.0 |  |  | Common stock |  |  | Liability |  |  |  | 73,349 |  |  |  | 0.02 |
8/3/2017 |  |  | 4.6 |  |  | Common stock |  |  | Liability |  |  |  | 9,779 |  |  |  | 1.13 |
9/8/2017 |  |  | 4.7 |  |  | Common stock |  |  | Liability |  |  |  | 28,764 |  |  |  | 1.05 |
6/19/2018 |  |  | 5.5 |  |  | Common stock |  |  | Liability |  |  |  | 17,977 |  |  |  | 1.05 |
6/25/2019 |  |  | 6.5 |  |  | Common stock |  |  | Liability |  |  |  | 8,988 |  |  |  | 1.05 |
|  |  |  |  |  |  |  |  |  |  |  |  | 436,711 |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-4 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481142/505-10-45-2 Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-10 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8 Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1 Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6 Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7 + Details
Name: | us-gaap_ScheduleOfStockByClassTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration